A phase II, double-blind, randomized, placebo-controlled, dose comparative study of the efficacy, tolerability, and safety of MCC-135 in subjects with chronic heart failure, NYHA class II/III (MCC-135-GO1 study): rationale and design
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Luigi Tavazzi John Cleland |
| Publication date | June 1, 2004 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |